Infection Control Market to be Worth Over $30.9 Billion by 2027 With CAGR of 6.3%| Top Key Players Like STERIS plc. , Cantel Medical Corp. , Getinge AB , Ecolab , 3M Company , Advanced Sterilization Products
Meticulous Research- leading global market research company published a research report titled “Infection Control Market by Product & Solution [Sterilization (Steam, Radiation, Indicators), Cleaning & Disinfection (Disinfectant, Equipment), Endoscope Reprocessing, Protective Barriers, Software], and End User (Hospital, Life Science)- Forecast to 2027”.
According to this latest publication from Meticulous Research®, the infection control market is expected to grow at a CAGR of around 6.3% during the forecast period of 2019–2027. This growth is mainly attributed to the rising number of surgical procedures, and growing prevalence of various hospital acquired infections (HAIs). The number of surgeries in developed & developing countries is continuously increasing due to rising prevalence of chronic diseases, unhealthy habits, and few other factors. In addition, rise in medical devices and pharma sectors in emerging countries due to the improvement in medical infrastructure and increase in the penetration of health insurance are creating strong revenue growth opportunities for players operating in this market.
Request Free Sample Report: https://www.meticulousresearch.com/request-sample-report/cp_id=5058
Key questions answered in the report-
Which are the high growth market segments in terms of product & solution type and end user?
What was the historical market for infection control market across the region?
What are the market forecasts and estimates for the period 2019–2027?
What are the major drivers, restraints, challenges, and opportunities in the infection control market?
Who are the major players in the infection control market?
What are the recent developments in the infection control market?
What are the different strategies adopted by the major players in the infection control market?
Growth Prospects in the Infection control Market
The infection control market study presents historical market data in terms of values (2017 and 2018), estimated current data (2019), and forecasts for 2027 – by Product & Solution [Sterilization (Steam, Radiation, Indicators), Cleaning & Disinfection (Disinfectant, Equipment), Endoscope Reprocessing, Protective Barriers, Software], and End User (Hospital, Life Science). The study also evaluates industry competitors and analyzes the market at regional level.
Have Any Query? Ask Our Expert:: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5058
Based on products & solutions, the infection control market is classified into sterilization products, cleaning and disinfection products, endoscope reprocessing products, protective barriers, and software. The cleaning and disinfection products segment accounted for the largest share of the overall infection control market in 2018. However, the endoscope reprocessing products segment is estimated to register fastest growth over the forecast period. The growth in this segment is mainly attributed to growing importance of diagnostic and therapeutic endoscopy procedures, availability of advanced technologies, and growing concern about risk of HAIs associated with use of improperly reprocessed endoscopes.
Directly Purchase This Report From Here:: https://www.meticulousresearch.com/buy_now.php?pformat=359&vformat=1063
Based on end user, the infection control market is mainly segmented into hospitals & clinics, medical device companies, and life science industry. In 2018, hospitals & clinics held the largest share of the infection control market, owing to the large patient footfalls in hospitals and growing need to curtail hospital-acquired infections (HAIs). Many a times, HAIs result in re-hospitalization and extended care delivery. This results in additional cost of care, in turn soaring the overall cost of care delivery. Thus, HAIs are considered as one of the major contributors to the overall healthcare spending in many of the countries. As HAIs can be prevented through efficient infection control policies, the increasing demand to curtail healthcare costs is expected to contribute to the growth of the infection control market among hospitals and clinics during the forecast period.
North America hold the largest share of the infection control market in 2019
In 2019, North America dominated the global infection control market. Continuous development in healthcare facilities, rise in prevalence of HAIs, increasing awareness regarding infection control among people are the major factors contributing to the largest share of North America in the global infection control market.
Here are the top Market companies in the world:: https://meticulousblog.org/top-10-companies-in-infection-control-market/
Some of the key players operating in the infection control market are STERIS plc. (U.S.), Cantel Medical Corp. (U.S.), Getinge AB (Sweden), Ecolab (U.S.), 3M Company (U.S.), Advanced Sterilization Products (U.S.), MMM Group (Germany), MATACHANA group (Spain), Belimed (Switzerland), and MELAG Medizintechnik oHG (Germany) among others.
By geography, infection control market is categorized into North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. In 2018, North America dominated the infection control market, while Asia-Pacific region is projected to register fastest growth during the forecast period of 2019-2027. In Asia-Pacific region, the growth is primarily driven by the increasing number of cases of emerging infectious diseases such as multidrug-resistant (MDR) organisms (MDROs) and pathogens with pandemic potential, rising number of surgical procedures, growing geriatric population and associated chronic conditions, and increasing investment in healthcare sector by governments in the region.
Download Sample Report Now !! https://www.meticulousresearch.com/download-sample-report/cp_id=5058
1. Clinical Trial Materials and Supplies Market by Service (Logistics, Manufacturing), Clinical Trial Type (Therapeutic, Diagnostics), Phase (Phase 2, Phase 3), Medical Specialty (Oncology, Diabetes), and End User (Pharmaceutical, CRO)- Global Forecast to 2025 https://www.meticulousresearch.com/product/clinical-trial-materials-and-supplies-market-5072/
2. In-Vitro Toxicology/Toxicity Testing Market by Product and Service, Technology (Cell Culture, OMICS), Method (Cell-based Assays, In-Silico), End-point (ADME, Genotoxicity, Organ Toxicity, Dermal Toxicity), End-user, and Geography – Global Forecast to 2025 https://www.meticulousresearch.com/product/in-vitro-toxicology-toxicity-testing-market-5047/
About Meticulous Research®
The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze and present the critical market data with great attention to details. Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, with the help of its unique research methodologies, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa regions.
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research